Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pleural malignancies

F S Vargas1, L R Teixeira

  • 1University of São Paulo, Brazil.

Current Opinion in Pulmonary Medicine
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Malignant pleural effusions are often caused by lung cancer, breast cancer, and lymphoma. Diagnosis involves identifying malignant cells, with videothoracoscopy recommended if initial tests fail. Treatment focuses on pleurodesis using agents like talc.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous and oral manifestations of pseudoxanthoma elasticum: clinicopathological features of an uncommon disorder.

Clinical and experimental dermatology·2020
Same author

Pleural fluid tumour markers in malignant pleural effusion with inconclusive cytologic results.

Current oncology (Toronto, Ont.)·2015
Same author

Comparison of intrarectal ozone, ozone administered in acupoints and meloxicam for postoperative analgesia in bitches undergoing ovariohysterectomy.

Veterinary journal (London, England : 1997)·2013
Same author

Effect of temperature and storage time on cellular analysis of fresh pleural fluid samples.

Cytopathology : official journal of the British Society for Clinical Cytology·2011
Same author

Pleural fluid cytokines correlate with tissue inflammatory expression in tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2010
Same author

Cytokine profile in pleural fluid and serum after lung transplantation.

Transplantation proceedings·2010
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Area of Science:

  • Oncology
  • Pulmonology
  • Pathology

Background:

  • Malignant pleural effusions are commonly associated with lung carcinoma, metastatic breast carcinoma, and lymphoma, accounting for about 75% of cases.
  • Diagnosis is confirmed by identifying malignant cells in pleural fluid or parietal pleura.

Purpose of the Study:

  • To review diagnostic methods for malignant pleural effusions.
  • To discuss treatment options for malignant pleural effusions, including pleurodesis and alternative therapies.

Main Methods:

  • Cytologic studies of pleural fluid and needle biopsy are initial diagnostic steps.
  • Morphometric procedures and quantitative analysis of nucleolar organizer regions are emerging diagnostic tools.
  • Videothoracoscopy is recommended for unresolved cases.

Related Experiment Videos

Main Results:

  • Malignant cells in pleural fluid or tissue confirm the diagnosis.
  • Several sclerosants, including talc and tetracycline derivatives, are used for pleurodesis.
  • Alternative treatments exist for patients unsuitable for chemical pleurodesis.

Conclusions:

  • Accurate diagnosis of malignant pleural effusion relies on cytological and histological examination.
  • Chemical pleurodesis with agents like talc is the standard treatment.
  • Management strategies should be individualized based on patient candidacy for pleurodesis.